This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


User:Brenton Horne/sandbox

From Proteopedia

Jump to: navigation, search

The structure of human aminopeptidase N (PDB code 4FYQ)

Drag the structure with the mouse to rotate

Aminopeptidase N (APN; CD13) is a zinc-dependent integral ectopeptidase that cleaves neutral amino acids from the N-terminal of peptides.[1] It has been implicated in coronovirus invasion of cells of the respiratory tract and numerous cancers.[1][2] Its expression in cancer cells has been associated with more aggressive phenotypes and a role for it has been determined in: breast cancer, colon cancer, stomach cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, pancreatic cancer and thryoid cancer.[1] It is also an enkephalinase, that is, it is an enzyme involved in the degradation of enkephalins, such as met-enkephalin and leu-enkephalin.[3] Additional roles in immunity have also been discovered (such as in the degradation of the pro-inflammatory cytokines, interleukin 8 and N-formyl-methionine-leucine-phenylalanine and in the regulation of T cell function) and the use of APN inhibitors has been proposed as a potential drug therapy for inflammatory bowel disease.[4]

References

  1. 1.0 1.1 1.2 Su L, Fang H, Xu W. Aminopeptidase N (EC 3.4.11.2) inhibitors (2006 - 2010): a patent review. Expert Opin Ther Pat. 2011 Aug;21(8):1241-65. doi: 10.1517/13543776.2011.587002. , Epub 2011 May 28. PMID:21619485 doi:http://dx.doi.org/10.1517/13543776.2011.587002
  2. Bosch BJ, Smits SL, Haagmans BL. Membrane ectopeptidases targeted by human coronaviruses. Curr Opin Virol. 2014 Apr 21;6C:55-60. doi: 10.1016/j.coviro.2014.03.011. PMID:24762977 doi:http://dx.doi.org/10.1016/j.coviro.2014.03.011
  3. Thanawala V, Kadam VJ, Ghosh R. Enkephalinase inhibitors: potential agents for the management of pain. Curr Drug Targets. 2008 Oct;9(10):887-94. PMID:18855623
  4. Bank U, Bohr UR, Reinhold D, Lendeckel U, Ansorge S, Malfertheiner P, Tager M. Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors. Front Biosci. 2008 May 1;13:3699-713. PMID:18508466

Proteopedia Page Contributors and Editors (what is this?)

Brenton Horne

Personal tools